The United Laboratories International Holdings Limited (HKG:3933)

Market Cap	24.06B
Revenue (ttm)	15.05B
Net Income (ttm)	3.12B
Shares Out	1.82B
EPS (ttm)	1.72
PE Ratio	7.70
Forward PE	7.43
Dividend	0.62 (4.65%)
Ex-Dividend Date	Sep 19, 2024

Volume	7,929,067
Average Volume	5,101,249
Open	12.60
Previous Close	12.60
Day's Range	12.52 - 13.30
52-Week Range	7.84 - 13.70
Beta	-0.04
RSI	61.24
Earnings Date	Mar 26, 2025

About HKG:3933

The United Laboratories International Holdings Limited, an investment holding company, engages in the research and development, manufacture, distribution, and sale of pharmaceutical products. It operates through three segments: Bulk Medicine, Intermediate Products, and Finished Products. The company offers oral antibiotics, antimicrobials for injection, anti-cold products, cough medicines, ophthalmic drugs, antiviral drugs, anti-hepatitis B drugs, diabetes drugs, skin drugs for external use, cardiovascular and cerebrovascular drugs, amoxicillin...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1990
• Employees: 15,000
• Stock Exchange: Hong Kong Stock Exchange
• Ticker Symbol: 3933

Financial Performance

In 2023, HKG:3933's revenue was 13.74 billion, an increase of 21.22% compared to the previous year's 11.33 billion. Earnings were 2.70 billion, an increase of 70.85%.

Financial numbers in CNY